Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Hum Mutat. 2008 Sep;29(9):1091–1099. doi: 10.1002/humu.20831

Figure 3.

Figure 3

Targeted CGH dystrophin array for clinical samples. The dystrophin gene coordinates are represented at the top, with exon 1 to 79 from right to left. The representative array results shown here for males and females are displayed in the scatter plot. Each pair shows results of CGH analysis using NimbleGen SegMNT. 1) 10 Mc - male with deletion of exon 18 (c.2169−?_2292+?del); 2) 4 Mc - male with deletion of exons 45–54 (c.6439−?_8027+?del); 3) 2 Mc -male with duplication of exon 2–4 (c.32−?_264+?dup); 4) 23 Mc - male with duplication of exons 35–44 (c.4846−?_6438+?dup); 5) 31 Mc - male with a 33-kb deletion in intron 1(c.31+?_32−?del) and an 11-kb deletion in intron 2 (c.93+?_94−?del); 6) 35 Fc - female with deletion of exons 49–50 (c.6615−?_7309+?del); and 7) 33 Fc - female with duplication of exon 44 (c.6291−?_6438+?dup); and 8) 34 Fc - female with duplication of exons 8–11 (c.650−?_1331+?dup).